Dasa Expands Its Capabilities with SOPHiA GENETICS

    • In just one year of using SOPHiA DDM™ HRD, Dasa reaches 2,000 samples analyzed 

      BOSTON and LAUSANNE, Switzerland, May 8, 2023 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and the leader in data-driven medicine, celebrates today with longstanding partner, Dasa, the largest integrated healthcare network in Brazil, as it reaches a milestone of 2,000 samples analyzed for HRD status. This milestone comes just one year after implementing the SOPHiA DDM™ Homologous Recombination Deficiency (HRD) Solution